DUBLIN--(BUSINESS WIRE)--The "Intrauterine Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.
The global intrauterine devices market reached a value of around US$ 3.7 Billion in 2017
The size of IUDs is similar to that of a match stick and their arms are folded flat so that they fit properly in the uterus. These devices are rapidly gaining popularity across the globe as they are effective, safe, long-acting and eliminate the need for other contraceptives. However, there are some adverse effects attached to the use of IUDs which include spotting, uterus perforation, irregular menstrual pattern and pelvic inflammatory diseases.
Over the years, it has been observed that more than a half of the pregnancies are mistimed, unwanted and unintended. On account of this, several governments and non-profit organizations are promoting the use of IUDs in confluence with educating the people about birth control measures and family planning. Moreover, various awareness programs are expected to increase the sales of IUDs in the upcoming years.
Additionally, the act of repealing Affordable Care Act (ACA) in the United States has encouraged a large section of women to choose for long-acting reversible contraception (LARC), such as IUDs, due to the lack of access to abortion and rising copayment. This is further supported by technological innovations, such as reusable and postpartum IUDs, which are anticipated to stimulate the market growth.
Looking forward, the market value is projected to reach about US$ 4.6 Billion by 2023, expanding at a CAGR of 3.8 % during 2018-2023.
The competitive landscape of the market has also been examined with some of the key players being Actavis, Bayer, Teva Pharmaceuticals, Allergan, Eurogine, OCON Medical, Pregna, HLL Lifecare, HRA Pharma, ANI Pharmaceuticals, Besins HealthCare, SMB, etc.
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
5 Global Intrauterine Devices Market
6 Market Breakup by Product
7 Market Breakup by End-Use
8 Market Breakup by Region
9 Intrauterine Devices Manufacturing Process
10 Competitive Landscape
- Actavis
- Bayer
- Teva Pharmaceutical
- Allergen
- ANI Pharmaceuticals
- Eurogine
- OCON Medical
- Pregna
- SMB Corporation
- HLL Lifecare
- HRA Pharma
- Besins HealthCare
For more information about this report visit https://www.researchandmarkets.com/research/rgxkkn/3_7_bn?w=4
